L

Lavipharm SA
ATHEX:LAVI

Watchlist Manager
Lavipharm SA
ATHEX:LAVI
Watchlist
Price: 0.998 EUR 0.2% Market Closed
Market Cap: 168.4m EUR

Lavipharm SA
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Lavipharm SA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
L
Lavipharm SA
ATHEX:LAVI
EPS (Diluted)
€0
CAGR 3-Years
-31%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
No Stocks Found

Lavipharm SA
Glance View

Market Cap
168.4m EUR
Industry
Pharmaceuticals

Lavipharm SA engages in the manufacture and import of pharmaceuticals and veterinary products. The company is headquartered in Athina, Attiki. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. The company is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.

LAVI Intrinsic Value
0.652 EUR
Overvaluation 35%
Intrinsic Value
Price
L

See Also

What is Lavipharm SA's EPS (Diluted)?
EPS (Diluted)
0 EUR

Based on the financial report for Jun 30, 2025, Lavipharm SA's EPS (Diluted) amounts to 0 EUR.

What is Lavipharm SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-45%

Over the last year, the EPS (Diluted) growth was -67%. The average annual EPS (Diluted) growth rates for Lavipharm SA have been -31% over the past three years , -45% over the past five years .

Back to Top